Title:
NAV1.8 INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/186102
Kind Code:
A1
Abstract:
The present invention provides a Nav1.8 inhibitor. Particularly, the present invention provides a compound represented by formula I, or a tautomer, a stereoisomer, a hydrate, a solvate, a pharmaceutically acceptable salt or a prodrug thereof, a preparation method therefor, and use thereof in the preparation of a drug.
Inventors:
ZHANG XUEJUN (CN)
LI JINPING (CN)
JIA YIMIN (CN)
CHEN HAOMIN (CN)
LI QUN (CN)
AN DAN (CN)
ZHANG BO (CN)
YANG JUN (CN)
LI LIE (CN)
LI JINPING (CN)
JIA YIMIN (CN)
CHEN HAOMIN (CN)
LI QUN (CN)
AN DAN (CN)
ZHANG BO (CN)
YANG JUN (CN)
LI LIE (CN)
Application Number:
PCT/CN2023/085508
Publication Date:
October 05, 2023
Filing Date:
March 31, 2023
Export Citation:
Assignee:
WUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY (CN)
International Classes:
C07D213/89; A61K31/44; A61P25/04; A61P29/00; C07D213/56; C07D237/20; C07D413/12; C07D417/12
Domestic Patent References:
| WO2022192487A2 | 2022-09-15 | |||
| WO2022188872A1 | 2022-09-15 |
Foreign References:
| CN112225695A | 2021-01-15 | |||
| CN112479996A | 2021-03-12 | |||
| CN112689633A | 2021-04-20 | |||
| CN111065383A | 2020-04-24 |
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: